Martínez, María Teresa <br/><br/>
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature.  [electronic resource] 

 -  Critical reviews in oncology/hematology  Jan 2016 
 - 96-106 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1879-0461 
<br/><br/><label>Standard No.: </label>10.1016/j.critrevonc.2015.08.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ado-Trastuzumab Emtansine<br/>Antibodies, Monoclonal, Humanized--chemistry<br/>Antineoplastic Agents--chemistry<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials, Phase III as Topic<br/>Disease Progression<br/>Female<br/>Humans<br/>Maytansine--analogs & derivatives<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--drug therapy<br/>Receptor, ErbB-2--metabolism<br/>Trastuzumab